BofA lowered the firm’s price target on Afya (AFYA) to $22 from $25.50 and keeps a Buy rating on the shares after updating the firm’s estimates to incorporate a more conservative scenario on potential seats additions on already existing courses, while highlighting that the firm expects gross tuition to continue growing in line with inflation in 2026.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AFYA:
- Afya Limited’s Earnings Call Highlights Robust Growth
- Afya’s Balanced Outlook: Revenue Growth Amidst Potential Challenges Justifies Hold Rating
- Afya Limited Reports Strong Growth in Q3 2025
- Afya reports Q3 adjusted EBITDA R$398.9M, up 14.6% y/y
- Afya Limited Reports Strong Q3 2025 Financial Results and Strategic Initiatives